I have been on the forefront of fighting to allow Medicare to negotiate prescription drug prices, limit the out-of-pocket costs to $35 a month for life saving insulin and reducing the cost of prescriptions for all families.
Cap out-of-pocket insulin costs at $35 per month.
Occurrences
Evidence
Axios reports that the Senate Health Committee backed an amendment by a 15-8 vote to extend a $35 monthly insulin cap to people with private insurance and add a pilot for uninsured patients. That shows the broader version is still being pursued rather than fully enacted.
Kiplinger says Medicare beneficiaries' insulin costs remain capped at $35 per month in 2026. That confirms the federal cap exists, but only within Medicare coverage rather than as a universal out-of-pocket limit.
Assessments
A $35 monthly insulin cap exists for Medicare beneficiaries, but the broader promise of capping out-of-pocket insulin costs at $35 for everyone has not been fully enacted. Recent congressional action shows the wider version is still pending, so this is only partial delivery rather than full fulfillment. There is no clear evidence here that Donald Norcross directly drove the outcome to completion, so the result should not be credited as a full delivery.